Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone

被引:50
作者
Fleming, R [1 ]
Deshpande, N [1 ]
Traynor, I [1 ]
Yates, RWS [1 ]
机构
[1] Royal Infirm, Univ Dept Obstet & Gynaecol, Concept Unit, Glasgow G31 2ER, Lanark, Scotland
关键词
AMH; follicle cohort; FSH; oocyte yield; PCOS;
D O I
10.1093/humrep/dei499
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: During excess FSH treatment, different categories of follicles can be discerned: those responding and appearing to grow immediately (FoIsS8) and those appearing subsequently during the follicular phase (FoIs/d). These follicular categories were explored in cycles of assisted reproduction in the context of follicular biology, including primordial follicle pool (PFP) depletion, age, insulin resistance and potential markers. METHODS: Follicular cohorts were examined in 365 conventional ART cycles and related to patient insulin sensitivity, plasma FSH and anti-Mullerian hormone (AMH). RESULTS: Age had no influence upon the FoIsS8 category but was associated with a significant (P < 0.005) decline in the Fols/d. In contrast, insulin-resistant polycystic ovary syndrome (IR-PCOS) showed a significant (P = 0.005) increase in FoIsS8. Circulating AMH correlated strongly with oocyte yield and FoIs/d. CONCLUSION: Age showed little impact on the initial follicular cohort, but a significant impact upon the secondary cohort, while insulin resistance appeared to promote the former category alone. The disturbance to follicular dynamics and AMH in IR-PCOS reflected a larger stockpile of FSH-sensitive follicles. Circulating AMH appears to represent all categories of antral follicles observed.
引用
收藏
页码:1436 / 1441
页数:6
相关论文
共 19 条
[11]   Mild stimulation in in vitro fertilization [J].
Macklon, NS ;
Fauser, BCJM .
WOMEN'S HEALTH AND DISEASE: GYNECOLOGIC AND REPRODUCTIVE ISSUES, 2003, 997 :105-111
[12]   Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? [J].
Muttukrishna, S ;
McGarrigle, H ;
Wakim, R ;
Khadum, I ;
Ranieri, DM ;
Serhal, P .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (10) :1384-1390
[14]   Increasing the daily dose of recombinant follicle stimulating hormone (Puregon®) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation [J].
Out, HJ ;
Braat, DDM ;
Lintsen, BME ;
Gurgan, T ;
Bukulmez, O ;
Gökmen, O ;
Keles, G ;
Caballero, P ;
González, JM ;
Fábregues, F ;
Balasch, J ;
Roulier, R .
HUMAN REPRODUCTION, 2000, 15 (01) :29-35
[15]   Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome [J].
Piltonen, T ;
Morin-Papunen, L ;
Koivunen, R ;
Perheentupa, A ;
Ruokonen, A ;
Tapanainen, JS .
HUMAN REPRODUCTION, 2005, 20 (07) :1820-1826
[16]   Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles [J].
Seifer, DB ;
MacLaughlin, DT ;
Christian, BP ;
Feng, B ;
Shelden, RM .
FERTILITY AND STERILITY, 2002, 77 (03) :468-471
[17]   Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve [J].
van Rooij, IAJ ;
Broekmans, FJM ;
te Velde, ER ;
Fauser, BCJM ;
Bancsi, LFJMM ;
de Jong, FH ;
Themmen, APN .
HUMAN REPRODUCTION, 2002, 17 (12) :3065-3071
[18]   DOUBLING THE HUMAN MENOPAUSAL GONADOTROPIN DOSE IN THE COURSE OF AN INVITRO FERTILIZATION TREATMENT CYCLE IN LOW RESPONDERS - A RANDOMIZED STUDY [J].
VANHOOFF, MHA ;
ALBERDA, AT ;
HUISMAN, GJ ;
ZEILMAKER, GH ;
LEERENTVELD, RA .
HUMAN REPRODUCTION, 1993, 8 (03) :369-373
[19]   Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment [J].
Weenen, C ;
Laven, JSE ;
von Bergh, ARM ;
Cranfield, M ;
Groome, NP ;
Visser, JA ;
Kramer, P ;
Fauser, BCJM ;
Themmen, APN .
MOLECULAR HUMAN REPRODUCTION, 2004, 10 (02) :77-83